Drug intelligence / Profile preview

Iopydol

Development stage: Unknown
Lead developer: Bracco Imaging
Modality: Small Molecules
Administration: Intrabronchial

Overview

Iopydol is a contrast medium primarily used in diagnostic imaging procedures such as bronchography and tracheobronchography. It was utilized as an alternative to propyliodone, particularly when the latter became unavailable. Its application facilitated the visualization of the tracheobronchial tree for diagnosing conditions like peripheral lung cancer, bronchiectasis, and neonatal tracheal stenosis.

Beyond the preview

Go deeper on Iopydol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iopydol.

Explore the full profile